Which has the lower trailing P/E, ALNY or LH?

LH has the lower trailing P/E: ALNY trades at 37.11 and LH at 25.52. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ALNY or LH?

Over the past five years, ALNY grew revenue faster — ALNY at a 47.53% CAGR versus LH at -2.62%.

Does ALNY or LH pay a bigger dividend?

LH pays a dividend (0.93% yield), while ALNY has no payments in the available dividend history.

Is ALNY or LH more profitable?

ALNY runs the higher net margin — ALNY at 16.82% versus LH at 6.99%.

How have ALNY and LH total returns compared?

Over the past 10 years, ALNY delivered 12.47% and LH delivered 10.66% annualized total return. Past performance doesn't predict future results.

Alnylam Pharmaceuticals, Inc. (ALNY) vs Labcorp Holdings Inc. (LH)

A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and Labcorp Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

ALNY

Alnylam Pharmaceuticals, Inc.

$29.40B

$219.72HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Labcorp Holdings Inc.

$25.30B

$308.49HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — ALNY vs LH

growth of $100 · dividends reinvested · last 10y

ALNY +222.0% (+12.4%/yr)LH +176.7% (+10.7%/yr)ALNY compounded faster over this window

ALNY LH

ALNY vs LH: by the numbers

•ALNY is the larger company ($29.40B vs $25.30B market cap).
•LH trades at the lower trailing earnings multiple (25.52 vs 37.11 P/E), one valuation lens rather than an overall verdict.
•ALNY converts more revenue to profit (16.82% vs 6.99% net margin).
•ALNY grew revenue faster over the past five years (47.53% vs -2.62% CAGR).
•LH pays a dividend (0.93% yield), while ALNY has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ALNY	LH
P/E ratio	37.11	25.52
Forward P/E	32.95	16.81
P/S ratio	6.12	1.76
P/B ratio	21.71	2.94
EV / EBITDA	27.47	13.80
FCF yield	1.85%	4.57%

Profitability

Metric	ALNY	LH
Gross margin	79.72%	27.85%
Operating margin	20.81%	11.27%
Net margin	16.82%	6.99%
ROE	59.67%	11.65%
ROIC	24.71%	8.02%

Dividends

Metric	ALNY	LH
Dividend yield	N/A	0.93%
Payout ratio	N/A	23.82%

Growth (annualized)

Metric	ALNY	LH
Revenue CAGR (5Y)	47.53%	-2.62%
EPS CAGR (5Y)	N/A	-8.00%
FCF CAGR (5Y)	N/A	-16.45%
Total return CAGR (5Y)	2.66%	6.27%

Frequently asked

Which has the lower trailing P/E, ALNY or LH?: LH has the lower trailing P/E: ALNY trades at 37.11 and LH at 25.52. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ALNY or LH?: Over the past five years, ALNY grew revenue faster — ALNY at a 47.53% CAGR versus LH at -2.62%.
Does ALNY or LH pay a bigger dividend?: LH pays a dividend (0.93% yield), while ALNY has no payments in the available dividend history.
Is ALNY or LH more profitable?: ALNY runs the higher net margin — ALNY at 16.82% versus LH at 6.99%.
How have ALNY and LH total returns compared?: Over the past 10 years, ALNY delivered 12.47% and LH delivered 10.66% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ALNY analysis Full LH analysis Interactive comparison tool

Dig into the metrics

Alnylam Pharmaceuticals P/E ratio Labcorp P/E ratio Labcorp dividend yield Alnylam Pharmaceuticals ROE Labcorp ROE Alnylam Pharmaceuticals operating margin Labcorp operating margin Alnylam Pharmaceuticals revenue growth Labcorp revenue growth Alnylam Pharmaceuticals free cash flow Labcorp free cash flow

Alnylam Pharmaceuticals & Labcorp appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.